Board of Directors approved the financial reports of December 31, 2021
· Issued by Maxigen Biotech Inc.
Close
Today's Information
Provided by: MAXIGEN BIOTECH INC.
SEQ_NO
1
Date of announcement
2022/03/21
Time of announcement
20:53:58
Subject
Board of Directors approved the financial reports
of December 31, 2021
Date of events
2022/03/21
To which item it meets
paragraph 31
Statement
1.Date of submission to the board of directors or approval by the board of
directors:2022/03/21
2.Date of approval by the audit committee:2022/03/21
3.Start and end dates of financial reports or annual self-assessed financial
information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):
2021/01/01~2021/12/31
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):511976
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):261027
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):89947
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):97466
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):87667
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):87667
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):1.21
11.Total assets end of the period (thousand NTD):1265184
12.Total liabilities end of the period
(thousand NTD):123466
13.Equity attributable to owners of parent end of the
period (thousand NTD):1141718
14.Any other matters that need to be specified:None
